rose 4.5% on September 11 after the Financial Times reported that private equity firm GTCR has struck a 4.1 billion euro ($4.8 billion) deal to buy Czech generic drugmaker Zentiva from Advent International. The deal has been finalised and is expected to be announced within days, the newspaper said.

#WatchOutFor#StockInNews#FundamentalViews#Miscellaneous

1,081 likes·57 comments